Acute diarrhea. Shigellosis
Conditions
Interventions
Intervention 1: The case group will be receive cap Yomogi (contains 250 mg dried yeast Saccharomyces boulardii) as a single dose per day. Cap Yomogi is produced by ARDEYPHARM GmbH company under the
Treatment - Drugs
The case group will be receive cap Yomogi (contains 250 mg dried yeast Saccharomyces boulardii) as a single dose per day. Cap Yomogi is produced by ARDEYPHARM GmbH company under the license No. 6409
The control group will receive Chickpea flour powder as a single dose per day. Chickpea flour powder is produced by Tarkhineh Company under the license No. 640920 and Operation license No.81, Tehran,
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 5 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: existence of acute diarrhea; mild and moderate dehydration; age between 2-5 years ; Failure to receive antibiotics and probiotic compounds in the past 1 month . Exclusion creteria: chronic diarrhea; malabsorption diseases ;dysentery;accompanying diseasesuch as diabetes; severe dehydration ;abdominal distention; suspected to intestinal obstruction; vomiting )
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of diarrhea. Timepoint: before intervention, afterintervention. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of diarrhea. Timepoint: before intervention, after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbolfazl Mahyar
Qazvin University of Medical Sciences, Qazvin
Outcome results
None listed